Health and developmental outcomes at 18 months in very preterm infants with bronchopulmonary dysplasia
Related Experiment Video
Updated: Sep 29, 2026

Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
M C Grégoire1, F Lefebvre, J Glorieux
1Université de Montréal, Hôpital Ste-Justine and Université de Montréal, Montréal, Canada.
Insights
Very preterm infants needing oxygen at 28 days but not 36 weeks (BPD-1) showed no increased risk of morbidities. However, those needing oxygen past 36 weeks (BPD-2) had more respiratory issues and developmental delays.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Developmental Pediatrics
Background:
- Very preterm infants often require respiratory support.
- Oxygen dependency at different post-natal or gestational ages may indicate varying risks for long-term morbidities.
Purpose of the Study:
- To assess the 18-month morbidities in very preterm infants.
- To compare outcomes for infants oxygen-dependent at 28 days but not 36 weeks (BPD-1) versus those oxygen-dependent at 36 weeks (BPD-2) and a comparison group.
Main Methods:
- A cohort of 217 infants born between 24-28 weeks gestation were categorized into three groups based on oxygen use.
- Outcomes assessed at 18 months included growth, respiratory problems, surgery, hospitalizations, and neurodevelopmental impairments.
Main Results:
- Infants in the BPD-1 group (oxygen < 36 weeks) showed no significant differences in growth, hospitalizations, or neurodevelopment compared to controls.
- Infants in the BPD-2 group (oxygen ≥ 36 weeks) experienced more hernia repairs, longer respiratory rehospitalizations, and lower developmental quotients.
Conclusions:
- Very preterm infants not oxygen-dependent by 36 weeks (BPD-1) have similar 18-month outcomes to non-oxygen-dependent peers.
- Prolonged oxygen dependency (BPD-2) is associated with increased respiratory morbidity, surgical needs, and developmental delays at 18 months.
Objective:
To determine whether very preterm infants who are oxygen-dependent at 28 days of life but not at 36 weeks' gestational age are at high risk of morbidities at 18 months.
Population:
A total of 217 infants born in a tertiary care center at 24 to 28 weeks' gestation in 1987 to 1992, classified into three groups: neonatal comparison group, O2 <28 days of life (n = 76); bronchopulmonary dysplasia (BPD)-1, O2 >/=28 days but not at 36 weeks' gestational age (n = 48); and BPD-2, O2 >/=36 weeks (n = 93).
Outcome Measures:
Growth, persistent respiratory problems (asthma, tracheostomy, home oxygen therapy), surgery, hospitalizations, and neurodevelopmental impairments.
Results:
Among the three groups, no differences were found in weight, height, head circumference, or total number of days of rehospitalizations for any causes, or in rate of rehospitalizations to the intensive care unit, persistent respiratory problems, cerebral palsy, or sensory impairment. Children with BPD-2 needed more hernia repairs compared with the other two groups (comparison group: 12% vs BPD-1: 10% vs BPD-2: 30%), had more days of readmissions for respiratory problems (comparison group: 2.0 vs BPD-1: 2.0 vs BPD-2 6.3 [BPD-1 vs BPD-2]), had a lower mean developmental quotient (comparison group: 97.4 +/- 15.0 vs BPD-1: 97.9 +/- 11.6 vs BPD-2: 90.7 +/- 19.3). Intraparenchymal cerebral lesions, high family adversity, and prolonged ventilation were the most important factors influencing the developmental outcome.
Conclusion:
Children with BPD-1 are similar in all respect at 18 months to children in the comparison group. Children with BPD-2 are similar to the other groups at 18 months in growth, general health, and neurologic outcome but differ in having a higher number of days of rehospitalizations for respiratory causes, more hernia repairs, and more developmental delays.
Related Concept Videos
Assessment of Respiration
Subjective Assessment: Nurses interview the patient to gather information directly during the subjective assessment. It includes questions about the individual's medical history, medications, and symptoms, focusing on past respiratory conditions like asthma or COPD,...
Pulmonary Cycle: Exhalation
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Respiratory Syncytial Virus Disease
Atelectasis II: Pathophysiology
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

